Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Correlation of the VEMP score, ambulation and upper extremity function in clinically isolated syndrome.
The Role of Geranylgeranyltransferase I-Mediated Protein Prenylation in the Brain.
Selective ORAI1 Inhibition Ameliorates Autoimmune Central Nervous System Inflammation by Suppressing Effector but Not Regulatory T Cell Function.
Acute optic neuritis: a clinical paradigm for evaluation of neuroprotective and restorative strategies?
Zoledronic acid improves bone mineral density in paediatric spinal cord injury.
Glatiramer Acetate in Treatment of Multiple Sclerosis: A Toolbox of Random Co-Polymers for Targeting Inflammatory Mechanisms of both the Innate and Adaptive Immune System?
Dendritic cells in multiple sclerosis: key players in the immunopathogenesis, key players for new cellular immunotherapies?
Neuropsychological rehabilitation for multiple sclerosis.
Assessment of microRNA-related SNP effects in the 3' untranslated region of the IL22RA2 risk locus in multiple sclerosis.
Atypical MRI features at early onset natalizumab-associated progressive multifocal leukoencephalopathy: A case report.
Ophthalmic manifestations of systemic diseases-part 2: metabolic, infections, granulomatoses, demyelination, and skeletal dysplasias.
Proteome analysis of post-transplantation recovery mechanisms of an EAE model of multiple sclerosis treated with embryonic stem cell-derived neural precursors.
A Long-Term Follow-Up Study Using IPMSSG Criteria in Children With CNS Demyelination.
Effect of vitamin D status on pharmacological treatment efficiency: Impact on cost-effective management in medicine.
Design of Peptide Immunotherapies for MHC Class-II-Associated Autoimmune Disorders.
Optical coherence tomography indicates disease activity prior to clinical onset of central nervous system demyelination.
Nitrous Oxide Abuse and Vitamin B12 Action in a 20-Year-Old Woman: A Case Report.
Evidence That Erythropoietin Modulates Neuroinflammation through Differential Action on Neurons, Astrocytes, and Microglia.
Individuals with neurological diseases are at increased risk of fractures within 180 days of admission to long-term care in Ontario.
EOP, a Newly Synthesized Ethyl Pyruvate Derivative, Attenuates the Production of Inflammatory Mediators via p38, ERK and NF-κB Pathways in Lipopolysaccharide-Activated BV-2 Microglial Cells.
Helicobacter pylori infection might prove the hygiene hypothesis in multiple sclerosis.
Neuro-nutraceuticals: Further insights into their promise for brain health.
Sjögren's syndrome and multiple sclerosis: Two sides of the same coin?
[A case of early systemic lupus erythematosus complicated with optic neuritis].
Consequences of neurologic lesions assessed by Barthel Index after Botox(®) injection may be underestimated.
Pages
« first
‹ previous
…
559
560
561
562
563
564
565
566
567
…
next ›
last »